Last reviewed · How we verify
dexmedetomidine 4μg
At a glance
| Generic name | dexmedetomidine 4μg |
|---|---|
| Sponsor | Tanta University |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Comparing the QoR of PECS Block and GA in Breast-conserving Surgery With Sentinel Lymph Node Biopsy (NA)
- The Improvement of Low-dose Esketamine on Postoperative Depression in Patients Undergoing Bariatric Surgery With Preoperative Depression (PHASE4)
- Effect of Different Doses Of Intrathecal Dexmedetomidine In Combination With Bupivacaine On Spinal Anesthesia (PHASE1)
- A Study of Dexmedetomidine Pharmacokinetics for Preoperative Sedation (PHASE4)
- Effect of Dexmedetomidine on Levels of Plasma Inflammatory Factor in Asthma Patients Undergoing General Anesthesia (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- dexmedetomidine 4μg CI brief — competitive landscape report
- dexmedetomidine 4μg updates RSS · CI watch RSS
- Tanta University portfolio CI